{"id":155199,"date":"2025-10-31T11:53:12","date_gmt":"2025-10-31T11:53:12","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/155199\/"},"modified":"2025-10-31T11:53:12","modified_gmt":"2025-10-31T11:53:12","slug":"fda-says-drug-makers-have-recalled-a-blood-pressure-medicine-tainted-with-a-cancer-causing-chemical","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/155199\/","title":{"rendered":"FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical"},"content":{"rendered":"<p class=\"mb-4 text-lg md:leading-8 break-words\">The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">New Jersey-based Teva Pharmaceuticals USA and drugs distributor Amerisource Health Services issued voluntary nationwide <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Product=216677\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:recalls;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">recalls<\/a> earlier this month of more than 580,000 bottles of various strengths of prazosine capsules, according to the FDA.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Doctors prescribe prazosin, which relaxes blood vessels, to help lower blood pressure. It also is sometimes prescribed for nightmares and other sleep disturbances caused by post-traumatic stress disorder.<\/p>\n<p>Advertisement<\/p>\n<p>Advertisement<\/p>\n<p>Advertisement<\/p>\n<p>Advertisement<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The FDA said in <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Product=216512\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:enforcement orders;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">enforcement orders<\/a> posted online that it has given the affected lots of the drug a Class II risk classification because some of the recalled medication may have nitrosamine impurities that are considered potentially cancer causing.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">According to the FDA, <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/control-nitrosamine-impurities-human-drugs\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:N-nitrosamine impurities;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">N-nitrosamine impurities<\/a> are a class of potentially cancer-causing chemicals that can form during manufacture or storage of a drug.<\/p>\n","protected":false},"excerpt":{"rendered":"The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the&hellip;\n","protected":false},"author":2,"featured_media":155200,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[90635,157,90634,90636,18,6915,135,19,17,462,90637],"class_list":{"0":"post-155199","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-amerisource-health-services","9":"tag-blood-pressure","10":"tag-cancer-causing","11":"tag-drug-makers","12":"tag-eire","13":"tag-food-and-drug-administration","14":"tag-health","15":"tag-ie","16":"tag-ireland","17":"tag-medication","18":"tag-teva-pharmaceuticals-usa"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115468645457568179","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/155199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=155199"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/155199\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/155200"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=155199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=155199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=155199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}